Product Specific References | - Lostrom, ME , Stone, MR, Tam M, Burnette WN, Pinter A, Nowinski RC. Monoclonal antibodies against murine leukemia viruses: identification of six antigenic determinants on the p15(E) and gp70 envelope proteins. Virology 1979 Oct 30;98(2):336-50.
- Hammerling U., Pinter A, and O'donnell PV, (1980) Monoclonal Antibodies as a tool in research on oncogenic viruses. p. 255-256. In G. A. Gerth (ed). The role of viruses in human cancer (Elsevier, Amsterdam).
- Pinter, A., Honnen, WJ, Tung, JS, O'Donnell, PV. Structural domains of endogenous murine leukemia virus gp70s containing specific antigenic determinants defined by monoclonal antibodies. Virology 1982 116(2):s 499-516
- Burkhart MD, Kayman SC, He Y, Pinter A. Distinct mechanisms of neutralization by monoclonal antibodies specific for sites in the N-terminal or C-terminal domain of murine leukemia virus SU. J Virol. 2003 Apr;77(7):3993-4003.
- Timilsina U, Umthong S, Lynch B, Stablewski A, Stavrou S. SERINC5 Potently Restricts Retrovirus Infection In Vivo. mBio. 2020;11(4):e00588-20. Published 2020 Jul 14. View article
- Umthong S, Lynch B, Timilsina U, Waxman B, Ivey EB, Stavrou S. Elucidating the Antiviral Mechanism of Different MARCH Factors. mBio. 2021 Mar 2;12(2):e03264-20. View article
|